For instance, mutations in TNFRSF13B, NFKB1, NFKB2, CTLA4 and STAT3 are indications for the early molecular diagnosis of patients with predominantly antibody deficiency such as predominantly antibody deficiencies (19). This evidence concerns the gene NFKB1 and agammaglobulinemia.